Will the Next Chapter of Nursery M&A Be Written By the Regulators?

For the better part of a decade, the nursery sector has been a textbook case of how to build value through consolidation. The ingredients were good – thousands of small, independently owned settings, demand that does not switch off in a downturn, and, since the expansion of funded hours, a large and growing slice of revenue underwritten by the state – albeit not without its challenges.

Buy the fragmented, professionalise it, centralise the back office and let scale do the rest. The groups that understood this early have been rewarded handsomely, and the appetite to keep building has, if anything, intensified. Of course, there have been various challenges over the years including throughout the Covid-19 pandemic, workforce struggles, increased regulatory scrutiny, perceived underfunded places and the recent statutory guidance on charging “extras”.

Scale, though, has a way of attracting attention. And in late May 2026, the sector quietly acquired a new and consequential reader. The Education Secretary wrote to the Competition and Markets Authority (CMA) asking it to examine two things: the extra charges families keep meeting – deposits, waiting-list fees, compulsory consumables, the suspicion that “free” hours come with conditions – and, in terms that left little to interpretation, the role of private equity in owning the nation’s nurseries. For anyone whose investment thesis rests on consolidating this market, that second clause is not background colour. It is a new variable in the model.

A note of proportion before going further.

Nothing has been decided, banned or even formally opened. The regulator has merely confirmed it was already watching and is willing to look harder. But sponsors are, by trade, in the business of pricing risks that have not yet crystallised, and this is a risk that deserves underwriting now rather than at exit.

A pattern worth studying, because the parallels are close

The most reliable guide to where this goes is not speculation about childcare but the regulator’s own recent conduct in markets that rhyme with it. The CMA has moved methodically through funerals, then veterinary services, and now private dentistry – and the selection criteria could have been written by an investment committee in reverse.

Fragmented ownership being rolled up into chains. Financial sponsors active in the consolidation. A service families cannot forgo. Prices that resist comparison. It is, almost exactly, the profile that made these sectors attractive to capital in the first place. The very features that create the opportunity are the features that draw the gaze.

The veterinary case is the one to read closely, because it has run its full course. After roughly two years of work, the regulator concluded in March 2026 that the market was not serving pet owners well, and imposed a remedy package that, stripped of its detail, requires operators to disclose who actually owns the practice – including whether it belongs to a large group – publish prices transparently, handle complaints properly and make switching easier. Larger groups were given less time to comply than independents. The regulator also pressed government to modernise a regime that held individuals to account but not the businesses behind them.

It is worth sitting with that ownership-disclosure remedy for a moment, because it is aimed squarely at group structures of this kind. The political and regulatory instinct on display is that the public has a right to know when the friendly local brand sits inside a national, sponsor-backed group – and that the group, not merely the registered manager, should answer for how the business is run. The dentistry study, opened only in March 2026 and due to report in early 2027, confirms this is a live programme rather than a closed file. The nursery letter is simply the next entry on the list.

There is one further point that bears directly on leveraged structures. The political framing here is not about charges in the abstract, it is about ownership and financial structure – about debt levels and how returns are generated from a service the taxpayer part-funds. The Southern Cross collapse still casts a long shadow over how regulators think about leverage in essential care. A more highly geared platform may find that its capital structure, not just its charging practices, becomes part of the conversation.

None of this makes returns illegitimate. Profit is the proper price of the capital that builds and sustains nursery places, and the better-run groups reinvest substantially. The live questions are ones of degree, resilience and transparency – not whether a business should earn a return at all.

What it does to the thesis

The discipline a sophisticated buyer should apply is to separate what changes from what does not. What does not change is the structural case for consolidation. The market is still fragmented, demand is still durable and the funded-hours settlement still underpins revenue. Buy-and-build is not over.

What changes is the quality of the earnings being acquired, and the breadth of the risk being underwritten. A meaningful portion of some targets’ profit sits in precisely the charges now under scrutiny – and since these businesses are bought and sold on a multiple of earnings, any future curtailment of those charges is value erosion at the full multiple, not at the margin.

The first task on any bolt-on is therefore to quantify, in pounds and as a share of EBITDA, how much of the profit depends on fee streams that a future remedy could trim, and to treat genuinely uncertain regulatory downside as a matter for deal structure – price, holdbacks, earn-outs, conditionality – rather than for warranties no well-advised seller will stand behind.

Three further considerations follow specifically from operating at platform scale.

First, integration cuts both ways. There is little sense paying for a clean, compliant bolt-on and then importing non-compliant group terms across it, and equally little sense inheriting a target’s problems into an otherwise tidy estate. Harmonise upward, deliberately.

Second, is property. Nursery economics are inseparable from their premises, and a platform wants leases with optionality – break rights, flexibility to reorganise, rather than rigid, long-dated commitments that become a liability the moment margins are squeezed or a setting needs rationalising. The lease must be scrutinised and stress-tested in depth to ensure that the setting can withstand future evolutions of the market and your safeguarding practices (this is what your future buyer will be looking at too).

Third, and the one most easily underestimated, is the aggregation risk. A single sub-threshold bolt-on attracts no merger scrutiny, however a sustained programme of them, building regional or national density, is exactly the kind of serial consolidation the regulator has shown elsewhere it is willing to examine. The deal that is invisible on its own may not be invisible as the twentieth of its kind.

The exit and the audience watching it

Sponsors do not buy to hold indefinitely, they buy to sell, and the hardest question this raises is not about the next deal but about the eventual one. Whatever you are diligencing today, your buyer at exit will diligence too – and they will price the regulatory overhang into the multiple they offer and the protections they demand. A platform assembled without due regard to charging transparency and clean compliance is a platform that will face a discount, a narrower buyer universe, or both, precisely when it matters most.

This is also where ownership structure quietly becomes a value variable in its own right. Patient, lower-geared capital – pension money and the like – is better placed to weather a transparency-and-resilience agenda than a more highly leveraged one, and the market will increasingly price that difference.

There is a reputational dimension that institutional investors feel keenly, too, being cast as the villain of an essential-services story carries a real cost with limited partners who are themselves sensitive to how their names appear in the press. Transparency, handled early and well, is better understood as a moat than as a burden – it widens the gap between the best-run platforms and the laggards, and that gap is where the next vintage of value will sit.

The structural case for building in this sector remains intact. What feels like a shift is that regulatory foresight has become a genuine source of edge. The regulator has, with some generosity, already published a script in two neighbouring industries – the platforms that read it and underwrite the regulatory terrain as carefully as they underwrite the financial one will be the ones still compounding value when the curtain rises on the nursery sector’s own act. The others will spend the next two years discovering, deal by deal, what they might have priced in from the start.

This is general comment on a developing regulatory situation and not advice on any particular transaction or investment. Acquirers should take tailored legal, financial and regulatory advice on their own circumstances.